GlobeStar Therapeutics Corp Quarterly Net Income (Loss) Attributable to Parent in USD from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
GlobeStar Therapeutics Corp quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q4 2010 to Q2 2024.
  • GlobeStar Therapeutics Corp Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$198K, a 84.6% increase year-over-year.
  • GlobeStar Therapeutics Corp Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$887K, a 53.5% increase year-over-year.
  • GlobeStar Therapeutics Corp annual Net Income (Loss) Attributable to Parent for 2023 was -$1.95M, a 31% decline from 2022.
  • GlobeStar Therapeutics Corp annual Net Income (Loss) Attributable to Parent for 2022 was -$1.49M, a 84.8% increase from 2021.
  • GlobeStar Therapeutics Corp annual Net Income (Loss) Attributable to Parent for 2021 was -$9.8M, a 1709% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$887K -$198K +$1.08M +84.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-10-11
Q1 2024 -$1.97M -$175K -$24.7K -16.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-10-11
Q4 2023 -$1.95M -$164K +$2.15K +1.3% Oct 1, 2023 Dec 31, 2023 10-Q 2024-10-11
Q3 2023 -$1.95M -$351K -$42.3K -13.7% Jul 1, 2023 Sep 30, 2023 10-K 2024-01-19
Q2 2023 -$1.91M -$1.28M -$1.12M -711% Apr 1, 2023 Jun 30, 2023 10-Q 2024-10-11
Q1 2023 -$783K -$150K +$538K +78.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-10-11
Q4 2022 -$1.32M -$166K +$167K +50.2% Oct 1, 2022 Dec 31, 2022 10-Q 2024-10-11
Q3 2022 -$1.49M -$308K +$3.95M +92.8% Jul 1, 2022 Sep 30, 2022 10-K 2024-01-19
Q2 2022 -$5.44M -$158K +$4.36M +96.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-17
Q1 2022 -$9.8M -$689K +$207K +23.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-08-17
Q4 2021 -$10M -$333K -$208K -168% Oct 1, 2021 Dec 31, 2021 10-Q 2023-08-17
Q3 2021 -$9.8M -$4.26M -$4.09M -2344% Jul 1, 2021 Sep 30, 2021 10-K 2023-01-09
Q2 2021 -$5.71M -$4.52M -$4.43M -5036% Apr 1, 2021 Jun 30, 2021 10-Q/A 2022-08-23
Q1 2021 -$1.28M -$896K -$778K -657% Jan 1, 2021 Mar 31, 2021 10-Q/A 2022-08-23
Q4 2020 -$505K -$124K +$36.6K +22.8% Oct 1, 2020 Dec 31, 2020 10-Q/A 2022-08-23
Q3 2020 -$542K -$174K -$18.4K -11.8% Jul 1, 2020 Sep 30, 2020 10-K 2022-01-05
Q2 2020 -$523K -$88K -$87.4K -16194% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-23
Q1 2020 -$436K -$118K +$72K +37.8% Jan 1, 2020 Mar 31, 2020 10-Q 2021-08-23
Q4 2019 -$508K -$161K +$167K +50.9% Oct 1, 2019 Dec 31, 2019 10-Q 2021-08-23
Q3 2019 -$675K -$156K +$64.2K +29.1% Jul 1, 2019 Sep 30, 2019 10-K 2020-12-03
Q2 2019 -$739K -$540 +$90.4K +99.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-14
Q1 2019 -$830K -$190K -$150K -373% Jan 1, 2019 Mar 31, 2019 10-Q 2020-07-14
Q4 2018 -$680K -$328K +$137K +29.5% Oct 1, 2018 Dec 31, 2018 10-Q 2020-07-14
Q3 2018 -$817K -$220K +$764K +77.6% Jul 1, 2018 Sep 30, 2018 10-K 2019-12-31
Q2 2018 -$1.58M -$91K +$91.7K +50.2% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-02
Q1 2018 -$1.67M -$40.2K +$155K +79.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$1.83M -$465K -$148K -46.6% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-19
Q3 2017 -$1.68M -$984K Jul 1, 2017 Sep 30, 2017 10-K 2019-01-03
Q2 2017 -$183K -$98.7K -118% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 -$195K +$14.3K +6.81% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-21
Q4 2016 -$317K -$110K -53% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-15
Q2 2016 -$790K -$83.9K +$183K +68.5% Apr 30, 2016 Jun 30, 2016 10-Q/A 2017-08-23
Q1 2016 -$973K -$210K +$94.6K +31.1% Jan 1, 2016 Mar 31, 2016 10-Q/A 2016-06-16
Q4 2015 -$1.07M -$208K +$18.1K +8.03% Oct 1, 2015 Dec 31, 2015 10-Q 2016-02-22
Q3 2015 -$1.09M -$289K -$73.7K -34.2% Jul 1, 2015 Sep 30, 2015 10-K/A 2016-01-22
Q2 2015 -$1.01M -$267K +$236K +47% Apr 1, 2015 Jun 30, 2015 10-Q/A 2015-09-24
Q1 2015 -$1.25M -$304K -$133K -77.4% Jan 1, 2015 Mar 31, 2015 10-Q/A 2016-06-16
Q4 2014 -$1.12M -$226K +$130K +36.5% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-22
Q3 2014 -$1.25M -$215K +$221K +50.6% Jul 1, 2014 Sep 30, 2014 10-K/A 2016-01-22
Q2 2014 -$1.47M -$503K -$325K -183% Apr 1, 2014 Jun 30, 2014 10-Q/A 2015-09-24
Q1 2014 -$1.14M -$172K +$64.3K +27.3% Jan 1, 2014 Mar 31, 2014 10-Q/A 2015-09-17
Q4 2013 -$1.21M -$356K -$260K -270% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-17
Q3 2013 -$946K -$437K -$221K -103% Jul 1, 2013 Sep 30, 2013 10-K/A 2015-01-27
Q2 2013 -$725K -$178K +$545K +75.4% Apr 1, 2013 Jun 30, 2013 10-Q/A 2014-09-04
Q1 2013 -$1.27M -$236K -$133K -129% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-20
Q4 2012 -$1.14M -$96K -$27.2K -39.6% Oct 1, 2012 Dec 31, 2012 10-Q/A 2014-02-21
Q3 2012 -$1.11M -$215K -$183K -565% Jul 1, 2012 Sep 30, 2012 10-K/A 2014-01-23
Q2 2012 -$926K -$722K -$705K -4044% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$221K -$103K -$101K -4796% Jan 1, 2012 Mar 31, 2012 10-Q/A 2013-05-16
Q4 2011 -$121K -$68.8K -$66.6K -3098% Oct 1, 2011 Dec 31, 2011 10-Q/A 2013-03-07
Q3 2011 -$54.1K -$32.4K Jul 1, 2011 Sep 30, 2011 10-K/A 2013-03-07
Q2 2011 -$17.4K Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-09-20
Q1 2011 -$2.1K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-21
Q4 2010 -$2.15K Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.